Edition:
United States

Intersect Ent Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

29.60USD
21 Sep 2018
Change (% chg)

$0.45 (+1.54%)
Prev Close
$29.15
Open
$29.45
Day's High
$29.90
Day's Low
$29.35
Volume
234,275
Avg. Vol
71,421
52-wk High
$42.90
52-wk Low
$25.15

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $887.75
Shares Outstanding(Mil.): 30.45
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 39.57 32.71
EPS (TTM): -0.60 -- --
ROI: -14.96 14.14 12.72
ROE: -15.04 17.36 14.84

BRIEF-Intersect ENT Reports Qtrly Loss Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

May 01 2018

Competitors

  Price Chg
Medtronic PLC (MDT.N) $97.85 +0.37

Earnings vs. Estimates